PODXL
Podocalyxin
Also known as: gp135, Gp200, PC, PCLP, PDX, PODXL_HUMAN, PODXL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00592
- Gene
- PODXL
- Ensembl
- ENSG00000128567
- Chromosome
- 7
- Canonical length
- 558 aa
- Protein class
- Plasma proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoli,Endoplasmic reticulum,Vesicles,Plasma membrane,Centriolar satellite
OverviewNCBI Gene
This gene encodes a member of the sialomucin protein family. The encoded protein was originally identified as an important component of glomerular podocytes. Podocytes are highly differentiated epithelial cells with interdigitating foot processes covering the outer aspect of the glomerular basement membrane. Other biological activities of the encoded protein include: binding in a membrane protein complex with Na+/H+ exchanger regulatory factor to intracellular cytoskeletal elements, playing a role in hematopoetic cell differentiation, and being expressed in vascular endothelium cells and binding to L-selectin. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
558 residues, UniProt reviewed canonical sequence.
>O00592|PODXL
1 MRCALALSAL LLLLSTPPLL PSSPSPSPSP SQNATQTTTD SSNKTAPTPA SSVTIMATDT
61 AQQSTVPTSK ANEILASVKA TTLGVSSDSP GTTTLAQQVS GPVNTTVARG GGSGNPTTTI
121 ESPKSTKSAD TTTVATSTAT AKPNTTSSQN GAEDTTNSGG KSSHSVTTDL TSTKAEHLTT
181 PHPTSPLSPR QPTSTHPVAT PTSSGHDHLM KISSSSSTVA IPGYTFTSPG MTTTLLETVF
241 HHVSQAGLEL LTSGDLPTLA SQSAGITASS VISQRTQQTS SQMPASSTAP SSQETVQPTS
301 PATALRTPTL PETMSSSPTA ASTTHRYPKT PSPTVAHESN WAKCEDLETQ TQSEKQLVLN
361 LTGNTLCAGG ASDEKLISLI CRAVKATFNP AQDKCGIRLA SVPGSQTVVV KEITIHTKLP
421 AKDVYERLKD KWDELKEAGV SDMKLGDQGP PEEAEDRFSM PLIITIVCMA SFLLLVAALY
481 GCCHQRLSQR KDQQRLTEEL QTVENGYHDN PTLEVMETSS EMQEKKVVSL NGELGDSWIV
541 PLDNLTKDDL DEEEDTHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PODXL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 131 nTPM
Expression across tissuesHPA
Tissue
- kidney: 131 nTPM
- retina: 63 nTPM
- fallopian tube: 46 nTPM
- heart muscle: 36 nTPM
- lung: 36 nTPM
- placenta: 28 nTPM
Single-cell type
- podocytes: 2,498 nCPM
- rod photoreceptor cells: 377 nCPM
- vascular endothelial cells: 298 nCPM
- pancreatic acinar cells: 290 nCPM
- cone photoreceptor cells: 193 nCPM
- endometrial luminal cells: 181 nCPM
Immune cell
- eosinophil: 0.3 nTPM
- gdT-cell: 0.2 nTPM
- MAIT T-cell: 0.2 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- thalamus: 76 nTPM
- cerebral cortex: 59 nTPM
- pons: 48 nTPM
- medulla oblongata: 47 nTPM
- midbrain: 45 nTPM
- amygdala: 44 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PODXL.
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 296 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive juvenile Parkinson disease 2
- PODXL-related disorder
ReferencesPubMed · IEDB
Publications for PODXL from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Comparative effects of plasmapheresis and intravenous cyclophosphamide on urinary podocyte excretion in patients with proliferative Lupus nephritis.
2002 · Clin Nephrol · RCR 0.7 · 22 citations - Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy.
2020 · Sci Rep · RCR 0.6 · 11 citations - Value of immunohistochemical expression of podocalyxin in active lupus nephritis.
2018 · Nefrologia (Engl Ed) · RCR 0.1 · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.67
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- cell migration
- negative regulation of cell adhesion
- negative regulation of cell-cell adhesion
- podocyte development
- positive regulation of cell migration
- positive regulation of cell-cell adhesion mediated by integrin
- regulation of microvillus assembly
- epithelial tube formation
Cellular components
Protein domainsUniProt · Pfam · InterPro
- CD34/Podocalyxin
- CD34/Podocalyxin family
- Podocalyxin
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PODXL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PODXL as an antibody target. Whether an autoantibody or antibody against PODXL could matter depends on whether native PODXL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PODXL is annotated at the cell surface, where native PODXL is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PODXL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...